CDK8-IN-13, CAS [[918523-75-8]]

Produktübersicht

• Artikelname: CDK8-IN-13, CAS [[918523-75-8]]
• Artikelnummer: BYT-ORB1737465
• Hersteller Artikelnummer: orb1737465
• Alternativnummer: BYT-ORB1737465-1, BYT-ORB1737465-1, BYT-ORB1737465-10, BYT-ORB1737465-100, BYT-ORB1737465-25, BYT-ORB1737465-5, BYT-ORB1737465-50
• Hersteller: Biorbyt
• Kategorie: Biochemikalien
• Alternative Synonym: CDK8, CDK8IN13, CDK8-IN-13, Apoptosis

Produktbeschreibung

CDK8-IN-13 is a potent, selective, and orally bioavailable CDK8 inhibitor (IC50 = 51.9 nM). It induces apoptosis, suppresses p-STAT1 S727 and p-STAT5 S726, and demonstrates anti-tumor activity in research models, supporting its use in oncology and signal transduction studies.

Produkteigenschaften

• Molekulargewicht: 237.26
• Reinheit: 99.28% (May vary between batches)
• CAS Nummer: [918523-75-8]
• Formel: C14H11N3O
• Target-Kategorie: Apoptosis,CDK

Anwendungsbeschreibung

• Anwendungsbeschreibung: Solubility: DMSO:112.5 mg/mL (474.16 mM)